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Journal of Hepatology 50 (2009) 211–214Test for hepatitis B virus infection with radical immunoassay
and real-time PCR: Which method is the gold standard?To the Editor:
We read with interest the study entitled What can be
revealed by extending the sensitivity of HBsAg detection
to below the present limit? by Togashi et al. [1]. We par-
ticularly appreciate their original contribution with re-
gard to HBsAg detection. Our concerns regarding this
study are outlined below.
The Authors believe that the radical immunoassay
method will become a powerful tool for worldwide pre-
vention of vertical and horizontal transmission of occult
HBV, including cases with a low virus load. We are
afraid we have reservations about this and cannot agree
with them.
Do the cases with a low virus load (less than 1.0 Lo-
g IU/ml) really have horizontal transmissibility except
for transfusion? The Authors’ opinion will make the
source of infection of hepatitis B expand factitiously
and consequently it may cause unnecessary panic in
the community.
Occult hepatitis B virus infection (HBV) can be de-
ﬁned as the long-lasting persistence of viral genomes in
the liver tissue (and in some cases also in the serum)
of individuals negative for the HBV surface antigen
(HBsAg) [2]. HBV DNA in liver tissue was not detected
in Togashi et al.’s study, and hence, we think the results
should be interpreted with caution.
To compare the radical immunoassay with that of
HBV DNA by real-time PCR, which method can reﬂect
the real infection of HBV? In other words, which meth-
od is the gold standard? In this study, high sensitivity
and high speciﬁcity can be obtained using the radical
immunoassay method, and is this method a gold stan-
dard for HBsAg? What about its repeatability? The
Authors did not mention it.
In this study, the Authors considered that the low
HBs antigenemia without HBV DNA group is uncer-
tain whether there is actual infection with a low HBVload, and may simply imply a false-positive. How
about the method’s negative predictive value and po-
sitive predictive value? In this study, among 34 cases
with low HBsAg positivity, only nine of 34 cases
HBV DNA were positive. If we considered real-time
PCR as a gold standard for HBV infection, the
method’s positive predictive value was only 26.5%
(9/34). That is to say, having a high sensitivity is
not necessarily a good thing, a test with 95% sensitiv-
ity might accurately identify as being aﬀected only
1% of those who test positive in the general popula-
tion [3]. When the tests are used in clinical practice,
we think that they will fail to be helpful.
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to below the present limit? Beyond the applause for higher sensitivity/j.jhep.2008.10.004To the Editor:
We read with great interest the article by Togashi et al.
[1] published in a recent issue of Journal of Hepatology.
Authors examined the sensitivity of a radical immunoas-
say they developed to detect hepatitis B surface antigen
(HBsAg) in comparison with real-time polymerase chain
reaction (PCR) detection of hepatitis B virus (HBV)
DNA. With higher sensitivity than EIA and chemilumi-
nescence immunoassay, they concluded that infection
with HBV, including occult HBV, is far more endemic
than suspected previously. Two issues need to be
addressed.
First, although Authors declared their analytical re-
sults appear to be reliable after performing the absorption
test on several low HBsAg-positive cases, the possible
false-positive result might be a considerable issue. Eleven
patients with negative anti-HBc, anti-HBs and HBV
DNA and four patients with negative anti-HBc and
HBV DNA but positive for anti-HBs (assumed to have
receivedHBV vaccination) had lowHBsAg by the radical
immunoassay in Table 3 [1]. The possible false-positive of
the radical immunoassay or the false-negative of the anti-
HBc results have to be considered and further investi-
gated. Besides, of the 34 patients listed in Table 3 [1], the
nine patients with low HBsAg and positive HBV DNA
all had low HBV DNA levels (mean: 1.52 Log IU/mL,
range = 1.0–2.3 Log IU/mL). Currently serum HBV
DNA level P2000 IU/mL is considered signiﬁcantly
associated with the risk of subsequent development of
cirrhosis and hepatocellular carcinoma [2–4] and as one
of the indications for treatment for HBeAg-negative
patients [5,6]. The development of higher sensitivity of
an assay might on one hand improve the conﬁrmatory
ability in diagnosis but also on the other hand result in
an irreconcilable clinical implication. With applausive
sensitivity forHBsAg detection, the conﬁrmation, valida-tion and clinical application of this radical immunoassay
has to be further elucidated.
References
[1] TogashiH,HashimotoC,Yokozawa J, SuzukiA, SugaharaK, Saito
T, et al. What can be revealed by extending the sensitivity of HBsAg
detection to below the present limit? J Hepatol 2008;49:17–24.
[2] Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of
hepatocellular carcinoma across a biological gradient of serum
hepatitis B virus DNA level. JAMA 2006;295:65–73.
[3] Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting
cirrhosis risk based on the level of circulating hepatitis B viral load.
Gastroenterology 2006;130:678–686.
[4] Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, et al.
Hepatitis B virus genotype and DNA level and hepatocellular
carcinoma: a prospective study in men. J Natl Cancer Inst
2005;97:265–272.
[5] Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology
2007;45:507–539.
[6] Liaw YF, Leung N, Guan R, Lau GK, Merican I, McCaughan G,
et al. Asian-Paciﬁc consensus update working party on chronic
hepatitis B. Asian-Paciﬁc consensus statement on the management
of chronic hepatitis B: a 2005 update. Liver Int 2005;25:472–489.
Ching-I Huang 1
Chia-Yen Dai 1,2,3
Jee-Fu Huang 1,2
Ming-Lung Yu 1,2,*
1Division of Hepatobiliary Medicine,
Department of Internal Medicine
2Faculty of Internal Medicine, College of Medicine
3Department of Occupational and Environmental
Medicine, Kaohsiung Medical University,
Kaohsiung, Taiwan
*Tel.: +886 7 3121101x7475; fax: +886 7 3123955.
E-mail address: d780178@kmu.edu.tw
